Category Archives: Reduced drug costs

Patented Medicines Regulations: UPDATE July 13, 2020

financial charts

As reported by Kelsey Rolfe of Benefits Canada, reforms to the Patented Medicines Pricing Review Board (PMPRB) have been upheld by the Federal Court. This decision followed an application for judicial review by Innovative Medicines Canada and 16 pharmaceutical companies who opposed the amendments which included: In setting drug prices, a “basket” of 11 other […]

Bill 92 amendments reduce drug costs, but so too will Quebec’s latest agreement

a pair of reading glasses

At the close of last year, the Quebec government passed Bill 92, An Act to extend the powers of the Régie de l’assurance maladie du Québec and to amend various legislative provisions. Among the eighty-four amendments contained in Bill 92, is the requirement for pharmacies to detail drug cost, markup, and dispensing and/or professional fees […]